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Retransplantation of the Liver 
BYERS W. SHAW Jr., M.D., ROBERT D. GORDON, M.D., 
SHUNZABURO IWATSUKI, M.D., and THOMAS E. STARZL, M.D., Ph.D. 
Improvements in operative technique, immuno-
suppression, and organ procurement have done 
much to enhance the probability that the liver recip-
ient will survive long term. Nevertheless, failure of 
an hepatic allograft continues to be a serious risk 
facing the liver recipient. Because no effective 
method of extracorporeal support is available for 
these patients, undergOing retransplantation is the 
only alternative that offers the potential for long-
term survival. 
In the Pittsburgh experience, the need for re-
transplantation has arisen in about 20 to 25070 of 
liver recipients. It can occur as the result of three 
basic causes - primary nonfunction, rejection, or as 
a result of technical difficulties - and can present in 
one of several different settings. The present report 
is a review of a previous study that examined the 
subject of retransplantation in depth. I 
METHODOLOGY AND DATA BASE 
A total of 70 patients of the combined Denver 
and Pittsburgh series required retransplantation. Of 
these, 21 were from the group of 170 patients trans-
rtamed in Denver between March I, 1963, and 
February 3, 1980, under azathioprine and predni-
sone immunosuppression. This group was not 
l!xamined in detail, but their survival data were 
<.:ompared with the group of 49 retransplanted pa-
tients operated on in Pittsburgh through August I, 
1984. 
In a retrospective review of patient records, the 
major ..:auses of hepatic graft failure virtuallv 
always ..:outd be assigned to one of the three main 
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categories just enumerated. A diagnosis of primary 
nonfunction was made if a graft never showed evi-
dence of initial function following its transplanta-
tion. The signs might include those of profound 
hepatic failure (severe hypoglycemia, deep coma, 
renal failure, marked coagulopathy, acidosis, and 
shock), or other less obvious signs of irreversible 
hepatic damage (massive increases in serum trans-
aminase levels, unrelenting daily increases in serum 
bilirubin levels, mental confusion, persistent coagu-
lopathy, or persistent renal insufficiency without 
other evident causes). 
I f a graft failed secondarily, following initial 
evidence of acceptable function, the cause was as-
signed to one of two other categories. Rejection was 
diagnosed if a chart review offered clinical support 
for that diagnosis or if histopathologic review of the 
removed graft showed evidence of rejection. Tech-
nical failures include, primarily, vascular throm-
boses and, ll!sS frequently, ..:omplications of biliary 
reconstruction or other errors in surgical technique. 
RESULTS 
Relative Incidence of Retransplantation 
Prior to the introduction of cyclosporine, re-
transplantation was employed infrequently. Only 21 
of 170 patients (12.4070) received second grafts. In 
the cyclosporine-treated group. of 323 total opera-
tions, 69 (21.4070) were retransplants. Of the 69 reo 
transplants, 60 were for second and nine for third 
grafts. Yearly breakdown of the relative frequency 
of retransplantation is shown in Figure I. 
Retransplantation did not occur with any dif-
ference In frequency that was dependent on the 
original cause of liver disease (Fig. 2). In addition, 
the causes of retransplantation did not occur with 
any difference in frequency among the various pri· 
mary disease categories (fig. 3). 
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FIG. 1. Liver tranlplants per calendar veer. (Reproduced with permission from Shlw et a1.1) 
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FIG. 2. Liver retransplantation with cyclolporine and prednisone: primary disease 
categories. IReproduced with permission from Shaw et al. 1) 
Relative Frequencies of the Causes 
of Retransplantation 
As indicated in Figure 4, rejection was the most 
(ommon reason for retransplantation. occurring in 
28 of the 49 (57CfJo) patients (15 of O~ adults and 13 
of 25 children). Technical failures accounted for 
graft failure in 10 (20CfJo) patients overall: 2 adults 
(8CfJo) and 8 children (32CfJo). The greater frequency 
of technical failures in children is statistically sig-
nificant (p < O.OS). 
Primary nonfunction occurred in II of the 49 
patients (220:0). It was the second most common 
reason for retransplantation in adults (7 of 24, or 
29CfJo) and the least common in children (4 of 2S, or 
16CfJo). 
Survival Data 
Life-table methods were used to produce and 
compare survival curves for various groups of pa-
tients in the study. Figure 5 shows the difference in 
survival following retransplantation in the azathio-
prine- and cyclosporine-treated groups. The former 
group had a 14CfJo I-year survival and no patient 
survived beyond 16 months. The cyclosporine group 
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FIG. 3. Indications for liver retransplantatlon: cyclosporine era. Primary nonfunction in 
patients. technical failure In 10. and rejection in 28. (Reproduced with permission from Shaw 
et al.1) 
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FIG. 4. Indications for retransplantation. (Reproduced wilh permission from Shawel aLI) 
obtained a 49010 survival rate for 6 months through 
2 years (no patient has died more than 6 months 
after retranspiantalion). 
Figure 6 shows a breakdown of survival curves 
comparing primary with secondary grafting in chil-
dren and adults. All patients who avoided retrans· 
plantation fared better than retransplanted patients. 
with 68.S OJo of the former and 49OJo of the latter 
surviving at least I year (p = 0.014). The I-year 
survival rate in adults requiring retransplantation 
was 42.3010 compared with 63.5070 in those with only 
primary grafting (p = 0.026). The parallel rates in 
children were 56.SOJo for those retransplanted and 
76.8070 for those receiving only one graft (p = 
0.042). The survival figures were bener for children 
than adults in the primary group (p = 0.038) but 
not in the retransplanted group (p = 0.159). 
No differences in survival following retrans-
plantation were evident in an examination of sur-
vival curves for different primary disease categories. 
Children with biliary atresia fared the best and 
adults with sclerosing cholangitis the worst, but the 
difference between these two extremes was not 
significant (p = 0.074). 
Figure 7 shows the survival curves for the dif-
ferent causes of retransplanlalion. Both the 
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FIG. 5. Actuarial survival aftar liver retransplantatlon; before and after the Introduction 
of cyclosporine-prednisone therapy. (Reproduced with permission from Shaw et al.1) 
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FIG. 6. Actuarial survival after liver retransplantation with cyclosporine and prednisone 
in pediatric and adult patients. (Reproduced With permission from Shaw et aLI) 
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FIG. 8. Effect of liver retransplantation on actuarial survivel. (Reproduced with permission 
from Shaw et aLl) 
rejection and the technical failure groups fared 
better than the primary non function group (p < 
0.03 for both comparisons). 
Overall Impact of Retransplantation 
The overall effect of retransplantation on sur-
vival data is shown in Figure 8. The lower curve 
assumes that all patients not receiving retransplanta-
tion would have died within a few weeks of their 
retransplantation date. A further illustration of the 
effect of retransplantation is shown in Table I. Be-
cause of an aggressive attitude toward early retrans-
plantation in Pittsburgh. only seven patients could 
be identified during the study period who should 
have been retransplanted but were not because an 
appropriate donor was never available. In five of 
these patients. the need for retransplantation arose 
as an emergency situation. requiring a new organ 
within hours to a few days. All five of these pa· 
tients died as a direct result of hepatic failure. The 
two patients, with chronic rejection. illustrate the 
other danger of waiting too long for retransplanta-
tion. Both were children who died of sepsis 
resulting from overimmunosuppression in the 
presence of increasing liver failure while waiting for 
an appropriate donor. 
TABLE 1. Seven Patients for Whom Donors 
Were Not Available in Time 
EDjgrp~ ul 
Grall failurr 
rl:chnlcal 
q~DChnical 
Primary nonfuncllon 
Acute reJeclton 
Acule reJecllon 
ChrOniC relecllon 
ChrOniC reJecllon 
Cjgrp~ 0/ 
[)ea,h 
Hepaltc Ilan[!rene 
Hemorrhage 
Hepallc failure 
Hepaltc failure 
Hepaltc failure 
SepsIS 
SepsIs 
Operative Blood Losses 
The mean operative blood losses for retrans-
plantation procedures compared with primary graft-
ing procedures are shown in Table 2. Considerably 
less blood was lost during the average retransplant 
operation than during the first operation. This is 
true in both adults and children. although in order 
to have a statistically significant difference in chil-
dren. one must eliminate from consideration three 
cases of arterial thrombosis. 
Influence of a Positive Cytotoxic 
Cross-Match 
Information about the presence of donor-
specific. cytotoxic T-cell antibodies in the serum of 
recipients was available in 148 patients. Cross-
matches were not done in another 92 cases. Table 3 
shows the relationship between a positive or nega-
tive cross-match and the requirement for retrans-
plantation. A positive cross-match was not associ-
ated with a higher incidence of retransplantation. In 
TABLE 2. Operative Blood Use: First Versus Second 
Hepatic Transplantation 1983 to 1984 
Fir.r( Gra" S<'mnd Grall p salu~ 
Adulls (n = 20) 
Mean 37.9 ~ 37.2" 16.5 ~ 12.9 0.05 
Meehan 29 16 0.02 
Ranlle -l - 157 I - 56 
Children (n = 16) 
Mean 1MK9~ 7,0 ~KhOKp 0.05 
E~KT t 10.6)t 
Median 10 IS 0.01 
Ranl!e 3 - 25 ;: - I I 
(2 - ]6)t 
'Values expressed are unlls of packed red blood cells. 
fIr cases of arlenallhrombosls are Included (see DiSCUSSIon •. 
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TABLE 3. Hepatic Retranaplantatlon: Influence of 
Donor-Specific Cytotoxic T-eell Antibodies 
k~tiw Pofitiw 
Cmu-Match Cross-Match Not aon~ 
No retranSplant 94 
Allr~p~u 27 
Rejected retnUlSpianu 16 
21 
6 
6 
76 
16 
8 
addition, the incidence of a posltlve cross-match 
was not different between those patients with pri-
mary grafting compared with those undergoing re-
transplantation. As noted in a previous report, the 
incidence of a positive cross-match increased from 
about 25 to 50'10 at the time of the first retransplan-
talion and to 75'10 at the time of tertiary grafting.2 
Tertiary Transplantation 
At the time of the study. a total of nine 
patients had been given three sequential hepatic 
allografts (Table 4). Five of these patients are still 
alive and continue to do well. Three are male chil-
dren and two are adults. 
The four who died were all patients for whom 
third transplants were attempted in rather desperate 
situations. As pointed out in an accompanying 
article in this issue of Seminars. survival following 
retransplantation has not been possible when the 
patient is taken back to the operating room in stage 
III or I V coma as the result of failure of the pre-
vious graft. 
LESSONS FROM THE CURRENT 
EXPERIENCE 
Technical Considerations 
Several concepts should be kept in mind when 
planning for a retransplamation. 
The usefulness of vascular grafts procured at 
the time of the donor hepatectomy has been noted 
previously.) This proves to be even more important 
in cases of retransplantauon resulting from a vascu-
lar thrombosis. since an alternate method of arterial 
or portal venous reconstruction may be required.4.S 
TABLE 4. Tenlary Hepatic Transplantation 
.s of August 1. 1984 
DHd "tJjllt 
Interval from second 
10 third transplant 7,IO.19.S7 days 13.28.41.120.264 days 
Survival after third 9.10.14.43 days 7.9.11.17.18 months 
Iransplant 
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In preparing the upper vena cava for anastomo-
sis to the new hepatic graft, the surgeon may obtain 
extra length by leaving the original anastomosis 
intact and sewing to a shon cuff of vena cava from 
the first liver (Fig. 9). Even if the sutures encom-
pass the first anastomosis, the extra length provided 
by the cuff of vein may prove to be critical. 
The success of biliary reconstruction during a 
retransplantation depends on careful assessment of 
the suitability of the recipient tissue to which the 
new bile duct is to be sewn. If a duct-to-duct 
anastomosis is planned, this means making cenain 
that all tissue from the previous donor duct be 
removed and that the remaining recipient bile duct 
is viable and still long enough to allow connection 
to the new donor duct without tension. If any 
doubts arise. choledochodochostomy should be 
abandoned in favor of anastomosis to a Roux limb 
of jejunum. In reusing a jejunal limb, the first site 
of duct anastomosis should either be excised or 
closed primarily and a new site prepared elsewhere 
along the limb for the duct anastomosis. 
In general. the difficulty of the recipient oper-
ation may vary greatly. depending on the time 
interval since the previous transplant, the cause of 
retransplantation. and on whatever might be respon-
sible for the density and extent of adhesion forma-
tion. As a rule. care should be taken to avoid overly 
Donor liver 
FIG. 9. Intact upper cav.1 anastomosis with shon cuff of 
vein from the liver being removed. which Is left In pl.ce 
for anastomosis with the n_ org.n. IReproduced with per-
mISSIOn from Stant." 
- ---~~--~ -~------
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aggressive blunt dissection, since the walls of blood 
vessels or suture lines often prove to be the weakest 
points in the areas being stressed. The best alterna-
tive is to use sharp dissection wherever possible, 
since any errors that are made will likely be less 
dramatic and easier to repair than disrupted anasto-
moses or large rents in vessel walls. 
The TIming and Setting of 
Retransplantation 
The need for retransplantation can occur in 
one of three settings: emergent, acute, and elective. 
Most often, success in the emergent or acute setting 
requires an effective organ procurement system and 
optimal use of all available donors. Proper planning 
of elective retransplantation demands balancing the 
risks of further attempts at saving the failing graft 
against the risks of reoperation. 
Aggressive acute rejection. arterial thrombosis. 
or primary nonfunction can all lead to such pro-
found hepatic failure that retransplantation is 
required emergently. Although only three patients 
of the 49 in this group fell into this category. during 
the same time period. five others in similar straits 
died before new donor organs could be located. In 
the setting of rejection. the emergent need for a new 
graft was indicated by the development of severe 
adult respiratory distress and a metabolic acidosis. 
accompanied by sudden increases in serum trans· 
aminase levels. For the two patients in this condi-
tionwho were successfully retransplanted. the sec-
ondary transplants were undertaken within 8 to 10 
hours of the onset of signs and symptoms. In the 
two patients who died when no donors were found. 
death occurred. despite all attempts to support these 
patients. within 8 and 18 hours of the onset of 
symptoms. 
When arterial thrombosis was the cause of 
emergent retransplantation. patients usually pre-
sented with signs of hepatic gangrene. including the 
appearance of air bubbles in the right upper qua-
drant on plain radiographs of the abdomen (see ac-
companying article on the deartcrialized graft). In 
all of the patients with this entity in this series. the 
time from development of signs to retransplantation 
was somewhat longer than for those undergoing 
emergency retransplantation for rejection. The two 
patients who died before new organs could be 
found also had survived with their infarcted grafts 
for several days. Hence. arterial thrombosis may 
afford a little more time than rejection for locating 
an appropriate donor. 
The need for retransplantation in the acute and 
elective settings occurs primarily as the result of re-
SEMINARS IN LIVER DISEASE - VOL. 5, NO.4, 1985 
jection. The decision to go ahead with retransplan-
tation in the acute setting is usually made when liver 
function tests continue to deteriorate persistently 
over a period of several days, despite adequate im-
munosuppression or with antirejection therapy. The 
decision in the elective setting can be somewhat 
more difficult. 
In attempting to make the proper decision 
about retransplantation, one should bear in mind 
several conclusions from the previous study. The l-
and 2-year survival rates after retransplantation ap-
proach those for primary grafting. All of the deaths 
have occurred within 6 months of retransplantation, 
and the major cause of death has been related to 
sepsis. No patient in a coma from acute failure of 
an hepatic allograft (all in the emergent setting) has 
survived long term. On the other hand, the retrans-
plant operation is usually accomplished with less 
difficulty than the first transplant, with the possible 
exception of those cases of arterial thrombosis 
wherein extensive arterial collaterals have had time 
to form. Finally, failure of a second graft, particu-
larly in the elective setting, does not preclude sur-
vival after a third, since five of nine such patients 
have obtained excellent long-term results. 
Before deciding to recommend elective retrans-
plantation. the surgeon must make a careful search 
for reversible causes of liver dysfunction. Drug 
toxicity, biliary obstruction, viral hepatitis, and. in 
particular, intra-abdominal abscess are a few of the 
more common entities that must be excluded. Liver 
biopsy may be used to help make the diagnosis of 
other causes of hepatic failure. One must avoid 
placing too much emphasis on the interpretation of 
histologic studies, however, without other evidence 
to support that interpretation. 
Findings that support a decision to retransplant 
a patient include: (1) signs of a chronic rejection 
that is not likely to be reversible. such as massive 
elevations of gamma glutamyl transpeptidase levels 
or a biopsy showing disappearance of bile ductules. 
arteriolar thickening, and extensive periportal fibro-
sis; (2) the persistent elevation of serum bilirubin 
levels in the first month above 10 mg/dl. which is 
unresponsive to two full courses of antirejection 
therapy. particularly if the bilirubin continues to 
increase each time immunosuppression is reduced to 
maintenance levels: (3) poor liver function that 
deteriorates even further whenever immunosuppres-
sion is reduced to maintenance levels. 
The primary goal in the elective situation 
should be to avoid maintaining barely adequate 
hepatic function through the use of overaggressive 
immunosuppression. The temptation often exists to 
give frequent intravenous boluses of steroids or to 
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try a series of alternative forms of therapy to avoid 
retransplantation. If the patient's overall health 
remains good and neither liver function tests nor 
biopsies show signs of chronic rejection, such 
efforts might be rewarded. However, once the clini-
cal condition deteriorates as the result of over-
zealous attempts to reverse rejection, the chances of 
surviving retransplantation diminish markedly. 
SUMMARY 
Since the introduction of cyclosporine-predni-
sone for primary immunosuppression, retransplan-
tation has become a feasible option for patients 
whose primary grafts are failing, which may result 
from primary graft nonfunction, intractable rejec-
tion. or consequent to technical complications. Al-
though survival of patients requiring second grafts 
is less good than in those whose initial graft func-
tions well. 2-year survival rates of 4917!o have been 
achieved in retransplanted patients, a record that 
mandates serious consideration of this approach 
when the primary graft begins to fail. In general. 
the retransplant procedure is technically easier. with 
401 
less blood loss, than is the initial operation. When 
the reoperation is done electively, it should be done 
before serious clinical deterioration compromises 
the chances for success. 
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